Lysando AG

10 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jun 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 25, 2026
The maintenance fee for Antimicrobial Agents (US 10,329,550) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
1 fee due Apr 27, 2027
The maintenance fee for Endolysin Obpgplys (US 9,169,472) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
1 fee due May 26, 2027
The maintenance fee for Method of reducing biofilms (US 10,485,854) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
1 fee due Oct 16, 2027
The maintenance fee for Antimicrobial proteins (US 11,958,890) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

2 terms have ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 10,137,175	Antimicrobial agents In force Ends no later than Jun 28, 2030 · From the USPTO record	In force	Ends no later than Jun 28, 2030	From the USPTO record
US 11,052,137	Antimicrobial agents In force Term ends Aug 3, 2030 · From the USPTO record	In force	Term ends Aug 3, 2030	From the USPTO record
US 9,169,472	Endolysin Obpgplys In force Term ends Aug 24, 2030 · High confidence	In force	Term ends Aug 24, 2030	High confidence
US 8,906,365	Antimicrobial agents In force Term ends Oct 2, 2030 · From the USPTO record	In force	Term ends Oct 2, 2030	From the USPTO record
US 10,485,854	Method of reducing biofilms In force Term ends Apr 27, 2031 · From the USPTO record	In force	Term ends Apr 27, 2031	From the USPTO record
US 9,534,223	Method of reducing biofilms In force Term ends Feb 22, 2032 · From the USPTO record	In force	Term ends Feb 22, 2032	From the USPTO record
US 10,329,550	Antimicrobial Agents In force Term ends Mar 8, 2035 · High confidence	In force	Term ends Mar 8, 2035	High confidence
US 10,184,120	Modified KZ144 Endolysin Sequence In force Term ends Oct 9, 2035 · High confidence	In force	Term ends Oct 9, 2035	High confidence
US 10,167,462	Modified EL188 Endolysin Sequence In force Term ends Dec 14, 2035 · High confidence	In force	Term ends Dec 14, 2035	High confidence
US 11,958,890	Antimicrobial proteins In force Term ends Jun 5, 2039 · From the USPTO record	In force	Term ends Jun 5, 2039	From the USPTO record

Also on record, not counted in the 10: 4 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 8 no status recorded

List them